TNFRSF18 and hepatocellular carcinoma: To be noted, high TNFRSF18 expression stratified a subgroup with significantly worse overall survival in TCGA-LIHC (p = 0.043) and ZS-HCC (p = 0.025) sets (Figure 4H).